Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Pacific Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer located in the Tianjin Economic-Technological Development Area, China. Operating as a subsidiary of the Tianjin Pharmaceutical Group, the company is dedicated to the development and production of chemical drug formulations. Its core therapeutic focus includes cardiovascular diseases, respiratory conditions, and gastrointestinal health. The company's manufacturing facilities are equipped with advanced production lines for tablets, capsules, and granules, all of which meet national GMP certification standards. Tianjin Pacific is recognized for its flagship products like Nifedipine and Cimetidine, which serve a broad patient base in the domestic market. Through continuous quality improvement and technical innovation, the company maintains a strong reputation for reliability and excellence in the Chinese pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Pacific.